3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Deglutition Disorders
1
Cognitive Dysfunction
1
Interventions
Cyclophosphamide
45
fludarabine
32
Methotrexate
24
blinatumomab
20
Vincristine
19
Dexamethasone
19
fludarabine phosphate
18
Specimen Handling
17
Cytarabine
17
Whole-Body Irradiation
14
Melphalan
13
Tacrolimus
12
Calcium Dobesilate
12
Biopsy
12
Mercaptopurine
11
Busulfan
11
merphos
10
Peripheral Blood Stem Cell Transplantation
10
Mycophenolic Acid
10
Thiotepa
9
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
9
Doxorubicin
9
venetoclax
8
ponatinib
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
Prednisone
8
Mesna
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Tablets
×
90 days
×
Clear all
No trials found.